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There are currently no reports of identification of stem cells in human gallbladder. The differences between human gallbladder and
intrahepatic bile duct (IHBD) cells have also not been explored. The goals of this study were to evaluate if human fetal gallbladder
contains a candidate stem cell population and if fetal gallbladder cells are distinct from fetal IHBD cells. We found that
EpCAM+CD44+CD13+ cells represent the cell population most enriched for clonal self-renewal from primary gallbladder. Primary
EpCAM+CD44+CD13+ cells gave rise to EpCAM+CD44+CD13+ and EpCAM+CD44+CD13− cells in vitro, and gallbladder cells expanded in
vitro exhibited short-term engraftment in vivo. Last, we found that CD13, CD227, CD66, CD26 and CD49bwere differentially expressed
between gallbladder and IHBD cells cultured in vitro indicating clear phenotypic differences between the two cell populations.
Microarray analyses of expanded cultures confirmed that both cell types have unique transcriptional profiles with predicted functional
differences in lipid, carbohydrate, nucleic acid and drug metabolism. In conclusion, we have isolated a distinct clonogenic population
of epithelial cells fromprimary human fetal gallbladderwith stemcell characteristics and found it to be unique compared to IHBD cells.
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259Identification of a candidate stem cell in human gallbladderIntroductionUnderstanding the resident stem cell populations of the
bile duct system is important for both basic biology and
developing therapeutic strategies to treat bile duct diseases.
The bile duct system is divided into IHBD and extrahepatic
bile duct (EHBD) systems. The EHBD system consists of the
common hepatic duct, gallbladder, cystic duct and the
common bile duct (CBD) (Hand, 1973; Cardinale et al.,
2010). The gallbladder stores bile while modifying its content
and concentration (Nakanuma et al., 1997; Frizzell and
Heintze, 1980).
There is a paucity of data characterizing stem cells in both
adult and fetal human gallbladders. In addition, the differ-
ences between IHBD and EHBD cells are not well understood.
The EHBD system, the liver and the ventral pancreas develop
from the posterior ventral foregut endoderm (Shiojiri, 1997;
Zaret andGrompe, 2008; Tremblay and Zaret, 2005). However,
the cell-intrinsic factors responsible for IHBD and EHBD system
specification are unclear. Recently, Spence et al. (2009) by
using a PDX1-Cre transgenic mouse showed that hepatocytes
and IHBD cells descend from Pdx1− cells while the EHBD cells
including the ventral pancreas derive from Pdx1+ cells. These
data were corroborated by a study in our lab, where we found
that adult mouse gallbladder stem cells have a distinct
phenotypic and expression profile compared to adult mouse
IHBD cells (Manohar et al., 2011). However, the differences
between human IHBD and EHBD cells have not yet been
explored.
The goals of this study were to evaluate if human fetal
gallbladder contains a clonogenic candidate stem cell popu-
lation and compare its phenotypic and expression profiles to
those of fetal IHBD cells. The evaluation of human fetal
gallbladder stem cells would have important ramifications for
the study of congenital diseases such as biliary atresia (Bassett
and Murray, 2008) and gallbladder carcinoma, the most
common malignancy of the bile duct system (Miller and
Jarnagin, 2008), because of the importance of stem cells in
development, tissue regeneration and cancer (Lagasse, 2008).
In addition, a comparison of human fetal gallbladder and IHBD
cells would further elucidate the ontogeny of bile duct cells
and represent the first time that the developmental differ-
ences between the human IHBD and EHBD cells have been
explored.
Stem cells are defined by their ability for single cell
self-renewal and lineage commitment (Wagers and
Weissman, 2004). We have previously used colony forming
assays along with single cell and morphogenesis assays to
characterize a resident stem cell population in adult mouse
gallbladder (Manohar et al., 2011). In this report, we adapt
these assays to the study of human cells. We identify an
EpCAM+CD13+CD44+ epithelial subpopulation from primary
human fetal gallbladder that can expand in vitro through
seven passages, exhibits single-cell self-renewal and en-
grafts in the subcutaneous space of immunodeficient mice.
Last, we found that expanded human IHBD cells and
gallbladder cells had distinct phenotypic and expression
profiles with many of the predicted functional differences
between both cell types mirroring those from our previous
report (Manohar et al., 2011). To our knowledge, this is the
first report to prospectively isolate a clonogenic epithelialpopulation from human fetal gallbladder and evaluate its
genealogy relative to IHBD cells.
Methods
Gallbladder and IHBD cell isolation and culture
Fetal liver and gallbladder tissues were obtained from the
Tissue Bank at the Magee Women's Hospital of UPMC. All
samples were between 19 and 23 weeks of gestation and none
of the fetal gallbladders were obtained from therapeutic
abortions. (Supplementary Table 1). The research protocol was
reviewed and approved by the Institutional Review Board for
Human Research Studies at the University of Pittsburgh.
Gallbladders were cut and opened along the middle in order
to expose the mucosa and placed in HBSS. Bile was washed off
by gently scraping the mucosal surface with blunt-ended
forceps. Liver samples were minced into small pieces.
Gallbladder and liver samples were incubated with EBSS/
10 mM EGTA/1% HEPES for 15 min at 37 °C and treated with
1 mg/ml Collagenase II (Invitrogen, CA) + 1 mg/ml Hyaluron-
idase (Sigma) + 100 μg/ml of DNase I (Roche, IN) for 1–1.5 h
followed by 0.25% Trypsin /0.1% EDTA (Fisher Scientific, MA)
for 30 min to obtain a cell suspension. Cell suspensions were
plated on irradiated rat feeder cells as described previously
(Manohar et al., 2011).
FACS analysis
FACS analysis and sorting and subsequent data analysis were
performed as previously described (Manohar et al., 2011).
LDAs were performed by sorting 1, 10, 25, 50, 100, 200, and
500 cells/well into respective (≥4) columns of 96-well
plates (Corning, NY) seeded with irradiated feeders. Colo-
nies were scored after 4–6 weeks post-plating and candidate
stem cell frequencies of sorted sub-populations determined
in L-Calc™ (StemCell Technologies, Vancouver). In experi-
ments involving expanded cell populations, primary identi-
fication of sorted populations involved gating of human
(HLA+) cells followed by epithelial (EpCAM+) cells.
Results
EpCAM is a human gallbladder epithelial cell marker
EpCAM is a cell surface marker that was first described in
colorectal cancer (Koprowski et al., 1979). Its expression has
since been found on a wide variety of epithelial cells such as
keratinocytes, thymic epithelial cells and IHBD cells (Balzar
et al., 1999; de Boer et al., 1999). Previously, we have
determined that mouse gallbladder epithelial cells were
EpCAM+, and subsequently used EpCAM to label these cells by
flow cytometry (Manohar et al., 2011). EpCAM expression has
also been observed on adult human gallbladder epithelial cells
(Momburg et al., 1987; Auth et al., 1993) but no evidence exists
for its expression in fetal gallbladder. We co-stained EpCAM
and CK19, a pan biliary marker (Moll et al., 1982) on cross
sections of fetal gallbladders and found that most CK19+ cells
were EpCAM+ (Fig. 1A). We subsequently used EpCAM
Figure 1 Human fetal gallbladder cells expand in vitro on rat feeder cells. (A) Sections of human fetal gallbladder were stained
with EpCAM (Red) and CK19 (Green), and counterstained for nuclear staining with Hoechst (Blue). Bottom two panels, the magnified
images of the white box (top panel). Most CK19+ cells were EpCAM+. (B) Representative pictures of two human gallbladder samples
indicating epithelial expansion (arrowheads) on lethally irradiated LA7 rat feeder cells; “p” indicates passage. (C) In vitro growth
conditions select for gallbladder epithelial (CD45−EpCAM+) cells. Flow cytometric analyses at primary and first expansion (p0) of two
gallbladder samples indicating strong enrichment of CD45−EpCAM+ cells after a single expansion in vitro (p0). The number values
assigned to the gates (red boxes) represent the percentage of total live gallbladder cells within that gate. Plots display 5% probability
contours. In all plots dead cells were gated out by propidium iodide staining (not shown). For the expanded cells, rat feeder cells were
gated out by HLA-ABC staining (not shown). (D) Expanded gallbladder cells exhibit hallmark ultrastructure of bile duct epithelial cells,
consisting of small cuboidal cells with defined apical–basolateral polarity and interdigitating lateral membranes. MV: Microvilli, N:
Nucleus, BM: Basement membrane. Unless specified otherwise, scale bars: 100 μm.
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non-epithelial cells.
Fetal gallbladder epithelial cells expand in vitro
Similar to our previous study on mouse gallbladder cells
(Manohar et al., 2011), human gallbladder cells were cultured
in vitro on lethally irradiated rat feeder cells that select for
epithelial growth (Ehmann et al., 1984). In total 28 fetal
gallbladder samples were processed (Supplementary table 1).
All samples placed in culture (n = 21) exhibited in vitro
expansion (Fig. 1B). The hallmarks of these cultures were
either cobblestone-like epithelial colonies or colonies com-
prising small cells with large nuclear to cytoplasmic ratios.
Flow cytometry analyses of primary and expanded gallbladder
cells at first expansion (p0) showed that feeder cells select for
epithelial (EpCAM+) cell expansion (Fig. 1C). EpCAM− cells
that were sorted from primary gallbladder did not proliferate
on rat feeder cells (data not shown). Expanded human
gallbladder cells had an ultrastructure typical of bile duct
epithelial cells expanding in vitro (Fig. 1D). They were smallcuboidal cells with defined apical–basolateral polarity, apical
microvilli and junctional apparatus. Importantly, feeder cells
were ultrastructurally distinct from human gallbladder cells
indicating that fusion was not taking place (Supplementary
Fig. 1). Last, we observed expansion of gallbladder cells for up
to seven passages. These data are similar to previous studies
with human gallbladder cells (Auth et al., 1993; Hoerl et al.,
1992).
CD13 and CD44 as candidate gallbladder stem
cell markers
Since there is a paucity of cell surface markers that select for
clonogenic human gallbladder cells, we screened primary and
expanded cells with a panel of 46 commercially available cell
surface markers of stem and progenitor cells (Supplementary
Table 2). As stem cells have the capacity for self-renewal or
clonogenicity, we predicted that expansion in vitro would
select for cells capable of self-renewal, thereby enriching for
potential stem cells. We have successfully used this approach
to identify mouse gallbladder stem cell markers (Manohar
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that were heterogeneously expressed on primary gallbladder
epithelial cells and enriched on expanded gallbladder cells. In
this manner, we hoped to identify clonogenic cell surface
markers.
Three primary and five expanded gallbladder samples were
screened with the foregoing panel of cell surface markers
(Supplementary table 3). We found that the phenotypic
profiles of primary gallbladder epithelial cells were variable,
with expression of CD54, CD133.2, CD166 and CD104 differing
between samples, indicating the potential difference be-
tween separate biological samples. Interestingly, expression
of CD13, CD44, CD49f and CD81 was consistently heteroge-
neous on primary gallbladder epithelial cells (Fig. 2A, Supple-
mentary table 3). CD13 (aminopeptidase N) has previously
been described as a stem cell marker in the developing mouse
liver (Kakinuma et al., 2009; Okada et al., 2011) as well in
human hepatocellular carcinoma (Haraguchi et al., 2010). In
addition, recent studies have indicated that CD44 (the
receptor for hyaluronic acid) is a human gallbladder cancer
stem cell marker (Shi et al., 2010, 2011). CD49f (integrin α-6)
has been shown to be a stem cell marker in fetal and adult
livers (Zheng and Taniguchi, 2003; Tsuchiya et al., 2007;
Kamiya et al., 2009), the breast (Stingl et al., 2006;
Shackleton et al., 2006) and more recently in the adult
mouse gallbladder (Manohar et al., 2011). We found that
CD44, CD49f, and CD81 co-stained almost completely
(Supplementary Fig. 2). Therefore, primary gallbladder
epithelial cells were divided into CD44+CD49f+CD81+ and
CD44−CD49f−CD81− fractions. We chose to focus on CD44
as we observed the cleanest separation of positive and
negative populations with this marker.
Co-staining of CD13 and CD44 on primary gallbladder
epithelial cells revealed additional heterogeneity (Fig. 2B).
We noted the presence of three distinct subpopulations of
EpCAM+ cells: CD44+CD13+, CD44−CD13+ and CD44−CD13−
cells. All three populations did not express the hematopoi-
etic or endothelial markers CD45, CD34 and CD36 (not
shown). The CD44−CD13+ subpopulation was the largest in
most samples (13 out of 15 samples analyzed), followed by
the CD44+CD13+ subpopulation. Heterogeneous expression
of CD13 and CD44 was confirmed by immunofluorescence
analysis (Fig. 2C). We then examined their expression on
expanded gallbladder cells to determine if these markers
were linked to self-renewal.
Interestingly, expanded EpCAM+ cells exhibited a re-
markably conserved phenotypic profile in culture suggest-
ing expansion of a homogeneous subpopulation of cells
(Supplementary table 3). Expanded EpCAM+ cells were CD44+
and heterogeneous for CD13 expression (Fig. 2D). Similar to
CD44 expression, CD81 and CD49f were expressed on all
expanded cells (data not shown). Therefore, we observed two
distinct subpopulations of expanded cells: CD44+CD49f+
CD81+CD13+ and CD44+CD49f+CD81+CD13− cells. For the
sake of simplicity, these subpopulations will be referred to as
CD44+CD13+ and CD44+CD13− subpopulations.
Analysis of the same gallbladder samples from primary
tissue and at first expansion (p0) revealed that the
frequency of CD44+CD13+ cells remained relatively constant
(Fig. 2E). Based on these data, we hypothesized that the
EpCAM+CD44+CD13+ cells in primary gallbladder represent-
ed those capable of clonogenic self-renewal.CD44 and CD13 enrich for clonogenic human
gallbladder cells from primary cells
In order to evaluate CD13 and CD44 as clonogenic gallblad-
der cell markers, we performed Limiting Dilution Analyses
(LDAs). The LDA assay quantifies the frequency of the
subpopulation of cells capable of forming colonies (Fazekas
de St, 1982) and was key to the isolation of hematopoietic
(Baum et al., 1992) and neural stem cells (Uchida et al.,
2000). More recently, our group has used LDAs to identify
mouse gallbladder stem cells (Manohar et al., 2011).
We first determined if CD44 and CD13 could independently
enrich for clonogenicity. We separated EpCAM+CD44+ and
EpCAM+CD44− cells from primary gallbladders and performed
LDAs with the sorted cells. EpCAM+CD44+ cells exhibited a
significantly higher colony forming unit (CFU) frequency
(1/17) than EpCAM+CD44− cells (1/66) (Table 1A). In a
separate experiment, EpCAM+CD13+ cells exhibited a signif-
icantly higher CFU frequency (1/28) than EpCAM+CD13− cells
(1/195) (Table 1A). Therefore, both CD13 and CD44 indepen-
dently enrich for colony forming cells.
We then determined if combined expression of CD13 and
CD44 further enriched for clonogenicity. In four independent
experiments representing four different human gallbladder
samples, EpCAM+CD44+CD13+, EpCAM+CD44−CD13+ and
EpCAM+CD44−CD13− subpopulations of cells were sorted
from primary gallbladders (Table 1B). In all experiments, we
noted that the EpCAM+CD44+CD13+ cells exhibited the
highest CFU frequency (ranging from 1/8 to 1/39) and the
EpCAM+CD44−CD13− cells the lowest (1/134 to 1/664). The
CFU frequency of EpCAM+CD44−CD13+ cells was statistically
the same as that of total epithelial or EpCAM+ cells. Of note,
EpCAM+CD44+CD13+ cells had a significantly higher CFU
frequency than the EpCAM+ cells in all experiments. These
data indicate that combined expression of EpCAM, CD44 and
CD13 significantly enriches for clonogenic gallbladder epi-
thelial cells, and EpCAM+CD44+CD13+ cells represent the
cells that expand in vitro.
CD44 and CD13 enrich for human gallbladder stem
cells from expanded cells
We then further tested clonogenic cells from expanded
gallbladder by performing LDAs with expanded EpCAM+
CD44+CD13+ and EpCAM+CD44+CD13− cells. The rationale
was that as primary EpCAM+CD44+CD13+ cells represent the
colony-forming cells and expand in vitro, it might be
possible to further enrich for clonogenicity by separating
expanded EpCAM+CD44+CD13+ cells and demonstrating
their colony-forming ability.
Expanded EpCAM+CD44+CD13+ cells were separated from
EpCAM+CD44+CD13− cells in four different human gallbladder
samples. In all samples analyzed, we observed that EpCAM+
CD44+CD13+ cells had a significantly higher CFU frequency
(ranging from 1/18 to 1/39) than EpCAM+CD44+CD13− cells
(1/77 to 1/208) but not significantly higher than total EpCAM+
cells (Supplementary table 4), mostly due to the low number
of CD13− cells present during the sorting experiments. These
data confirm that CD44 and CD13 enrich for clonogenicity,
but also indicate that in vitro culture selects for a more
homogeneous expansion of primitive cells.
Figure 2 CD13 and CD44 highlight distinct heterogeneity on primary gallbladder epithelial cells and EpCAM+CD44+CD13+ cells expand in
vitro. (A) Flow cytometric profile showing that CD13 and CD44 are heterogeneous in primary human fetal gallbladder epithelial cells. Flow
plots represent only EpCAM+CD45− live cells from primary gallbladder (see Fig. 1C). (B) Co-staining of CD13 and CD44 identified three
subpopulations in primary human fetal gallbladder epithelial cells: CD13+CD44+, CD44−CD13+ & CD13−CD44− cells. (C) Immunofluores-
cence analysis of primary gallbladder sections stained with CD44 (Red), CD13 (Green) and counterstained with Hoechst (blue). Images were
taken of luminal cells that correspond to epithelial cells. We observed distinct CD44+CD13+ (white arrows) and CD44−CD13+ populations
(white arrowheads). CD44−CD13− cells were not noted probably because of the low frequency of the population (see Fig. 1). (D) Flow
cytometric profiles showing that expanded gallbladder cells are CD44+ and heterogeneous for CD13. Rat feeder cells and any HLA + EpCAM−
cells have been gated out of these plots. (E) Analyses on the same gallbladder sample fromprimary tissue (d0) and first expansion (p0) suggest
that the frequency CD44+CD13+ cells remains constant at early passage. Plots display 5% probability contours and the number values assigned
to the gates (red boxes) represent the percentage of live gallbladder epithelial (EpCAM+CD45−) cells within that gate. Scale bars: 100 μm.
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Table 1 Primary EpCAM+CD44+CD13+ gallbladder cells are
the most enriched in colony forming ability. (A) In two
biologically separate experiments, LDAs were carried out on
EpCAM+CD44+ and EpCAM+CD44− or EpCAM+CD13+ and
EpCAM+CD13− cells. LDAs were performed on total EpCAM+
cells as controls. CFU frequency ± SE (L-Calc®) indicates
CD13 and CD44 each independently enrich for colony forming
ability. (B) Data from four biologically separate experiments
indicating that EpCAM+CD44+CD13+ cells have the highest
colony forming ability. “N/A” not performed because of
insufficient cell number.
Sample Sorted population CFU SE in CFU
A
GB15 (d0) EpCAM+ 1/38 1/27–1/54
EpCAM+CD44+ 1/17 1/12–1/25
EpCAM+CD44− 1/66 1/47–1/94
GB18 (d0) EpCAM+ 1/24 1/17–1/33
EpCAM+CD13+ 1/28 1/21–1/39
EpCAM+CD13− 1/195 1/125–1/303
B
GB10 (d0) EpCAM+ 1/309 1/247–1/388
EpCAM+CD44+CD13+ 1/39 1/28–1/56
EpCAM+CD44−CD13− 1/664 1/428–1/1030
EpCAM+CD44−CD13+ 1/418 1/285–1/614
GB19 (d0) EpCAM+ 1/22 1/16–1/30
EpCAM+CD44+CD13+ 1/8 1/5–1/13
EpCAM+CD44−CD13− 1/134 1/65–1/274
EpCAM+CD44−CD13+ 1/23 1/16–1/33
GB26 (d0) EpCAM+ 1/37 1/27–1/51
EpCAM+CD44+CD13+ 1/12 1/8–1/18
EpCAM+CD44−CD13− N/A
EpCAM+CD44−CD13+ 1/44 1/31–1/62
GB27 (d0) EpCAM+ 1/47 1/35–1/65
EpCAM+CD44+CD13+ 1/17 1/12–1/24
EpCAM+CD44−CD13− N/A
EpCAM+CD44−CD13+ 1/67 1/49–1/97
263Identification of a candidate stem cell in human gallbladderEpCAM+CD44+CD13+ cells grow from single cells
Stem cells are usually defined by their ability to expand from
single cells. We tested the ability of primary EpCAM+CD44+
CD13+ cells to grow from single cells. In two separate
experiments, primary gallbladder cells were labeled with
the lipophilic membrane labeling red fluorescent dye PKH26
(Cicalese et al., 2009) to allow for single-cell visualization.
Single EpCAM+CD44+CD13+ cells were sorted into 96-well
plates and imaged (Fig. 3). To account for inter-sample
variability in CFU frequency (Table 1), we ran LDAs with the
EpCAM+CD44+CD13+ cells to have an accurate measure of
clonal frequency relative to each specific sample.
In both experiments, EpCAM+CD44+CD13+ cells exhibited
robust single cell self-renewal at a CFU frequency similar to
that obtained by LDA (Fig. 3A). All clones generated in this
manner (n = 6) were capable of serial passage on the LA7
feeder cells (Fig. 3B) indicating that these cells are capable of
single cell self-renewal and long-term expansion. Importantly,
when similar experiments were performed with EpCAM+CD44-CD13+ cells, no clones were generated (data not shown). We
did not attempt clonal assays with EpCAM+CD44−CD13− cells
as they have the lowest CFU frequency amongst the three
candidate subpopulations (Table 1) and insufficient cell
numbers made these experiments technically challenging.
Clonal analyses were also carried out with expanded
gallbladder cells to confirm that they retain the ability for
single cell self-renewal. In this experiment, single EpCAM+
cells were sorted onto 96-well plates and imaged. As the CFU
frequency of total EpCAM+ cells from expanded gallbladder
was not significantly different from that of expanded
EpCAM+CD44+CD13+ cells (Supplementary Table 4), we
reasoned that sorting total EpCAM+ cells would be an
appropriate assay to determine clonal self-renewal. Similar
to the primary gallbladder cells, expanded gallbladder cells
exhibited single cell self-renewal (Fig. 3B), and the clones
generated were capable of serial passage (data not shown).
Finally, we evaluated if single EpCAM+CD44+CD13+ cells
could exhibit gallbladder differentiation or morphogenesis.
Single primary EpCAM+CD44+CD13+ cells were sorted into
matrigel supplemented with Epidermal Growth Factor (EGF)
(50 ng/ml), Noggin (100 ng/ml) and R-spondin2 (1 mg/ml)
and Wnt3a (100 ng/ml). We were particularly interested to
determine if R-spondin2 and Wnt3a, two Wnt pathway
effectors, would support in vitro expansion and morphogen-
esis of gallbladder cells, similar to Lgr5+ liver stem cells (Huch
et al., 2013). Given the importance of the Wnt-dependent
pathway for stem cell expansion, we reasoned that clonogenic
gallbladder cells could possibly be expanded under the
previously defined organoid culture conditions (Huch et al.,
2013; Barker et al., 2009; Sato et al., 2009). Every EpCAM+
CD44+CD13+ single sorted cell formed cysts that grew into
large organoids that expressed CD44 and CD13. Without the
presence of the Wnt factors, the cultures deteriorated within
a few passages (not shown).
In all, these data confirm that primary EpCAM+CD44+
CD13+ cells are capable of single cell expansion and in vitro
morphogenesis.Expanded gallbladder cells can engraft in vivo
We have shown that gallbladder cells can expand long-term
(Npassage 3) in vitro. We then determined if they could
survive and engraft in vivo. An ideal site for engraftment is
the native gallbladder. As there are currently no protocols
that allow for the native engraftment of gallbladder cells,
we chose an ectopic site. The engraftment of in vitro
explants of human gallbladder cells has been noted in the
subcutaneous space of athymic nude mice (Okumura et al.,
1988). In addition, we have demonstrated the short-term
engraftment of adult mouse gallbladder stem cells in the
subcutaneous neck space (Manohar et al., 2011).
Obtaining sufficient numbers of primary EpCAM+CD44+
CD13+ cells proved technically challenging for injections. As
the CFU frequency of expanded EpCAM+ cells was statistically
the same as expanded EpCAM+CD44+CD13+ cells (Supplemen-
tary table 4), we considered total EpCAM+ cells expanded
in vitro to be a relatively homogeneous population of
clonogenic gallbladder cells, and consequently used these
cells in downstream analyses. We injected expanded EpCAM+
gallbladder cells premixed with collagen supplemented with
Figure 3 Primary and expanded gallbladder cells exhibit single cell self-renewal and morphogenesis. (A) Single cell clonal assays
were performed on primary and expanded GB. Primary cells (EpCAM+CD44+CD13+ and EpCAM+CD44−CD13+) and expanded cells
(EpCAM+) were pre-labeled with the red fluorescent dye PKH26 and single cell sorted into 96-well plates and imaged. LDA sorts for
primary cells were performed on the same populations in order to determine their CFU frequencies. Clonal colonies were calculated
6–10 weeks post plating. Both primary EpCAM+CD44+CD13+ and expanded EpCAM+ cells exhibited clonal self-renewal; however
primary EpCAM+CD44−CD13+ cells did not (data not shown). (C) Top panel: single cell EpCAM+CD44+CD13+ (Day 1 to 12) cultured on
matrigel in media containing AdDMEM/F12 (Invitrogen) supplemented with B27 and N2 (Invitrogen), 1.25 mM N-acetylcysteine
(Sigma-Aldrich), 10 nM gastrin (Sigma-Aldrich) and the following growth factors: 50 ng/ml, EGF (Peprotech), 1 mg/ml, Rspo2
(Peprotech),10 mM nicotinamide (Sigma-Aldrich), Noggin (100 ng/ml), Wnt3a (100 ng/ml). Bottom Panel, Day 12 cultures co-stained
with EpCAM/CK19 or CD44/CD13 indicate that organoids were EpCAM+CK19+ and heterogeneous for CD44 and CD13 expression.
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of immunodeficient mice. We observed survival and engraft-
ment of CK19+ gallbladder epithelial cells at one week
post-injection (Fig. 4A). However, there did not appear to be
any apparent structure formation. Engraftment was observed
in 3 out of 3 mice (100%) at one week, 2 out of 3 (67%) at two
weeks. No engraftment was observed at three weeks.
Cells isolated from engrafted areas at one week post
injection and expanded in vitro successfully reinitiated
primitive gallbladder cultures that were CD44+ and hetero-
geneous for CD13 (Fig. 4B).
Expanded human gallbladder cells are unique
compared to human IHBD cells
A recent study has shown that IHBD and EHBD systems develop
from separate progenitors duringmouse development (Spenceet al., 2009). In addition, we have previously shown that adult
mouse gallbladder cells have distinct phenotypic and expres-
sion profiles compared to IHBD cells (Manohar et al., 2011).
However, there are no reports of the molecular differences
between human gallbladder and IHBD cells.
Our goal here was to compare candidate human fetal
gallbladder cells to human fetal IHBD cells. However, we
reasoned that as the phenotypic profiles of primary human
gallbladder cells were variable, similar variability would be
obtained with primary IHBD cells making evaluation of
phenotypic differences difficult. Moreover, separating suffi-
cient numbers of either primary gallbladder epithelial− or
IHBD epithelial cells would be challenging for microarray
analyses. Therefore, we chose to compare expanded total
EpCAM+ gallbladder and IHBD cells to each other.
Briefly, fetal livers from age-matched donors (Supple-
mentary table 1) were digested and cell suspensions were
Figure 4 Expanded gallbladder cells engraft in vivo. (A) Expanded gallbladder cultures were mixed with collagen supplemented
with rhEGF (50 ng/ml) and injected into the subcutaneous space of Rag2−/−γC−/−mice. Candidate engrafted areas were dissected out
and stained with an anti-human CK19 to test the presence of human cells. Engraftment was observed at 1 week in 3 out of 3 mice and
at 2 weeks in 2 out of 3 mice in two separate human gallbladder cultures. No engraftment was observed at 3 weeks (0 out of 2 mice).
Representative images of engrafted areas at 1 week post injection. (B) Phenotypic profile of gallbladder cells does not change in vivo.
Flow cytometric analyses of gallbladder cells isolated at 1 week post injection show that the cells are CD44+ and exhibit clear
heterogeneity for CD13. These cells re-expanded in vitro but eventually lost CD13 heterogeneity. Debris and cell aggregates were
gated out in each plot. The middle plot represents HLA+EpCAM+CD45/TER119− cells from engrafted areas. All plots display 5%
probability contours and the number values assigned to the gates (red boxes) represent the percentage of live gallbladder epithelial
(EpCAM+CD45−) cells within that gate. Scale bars: 100 μm.
265Identification of a candidate stem cell in human gallbladdergrown on lethally irradiated LA7 feeder cells. We observed
that at least two serial passages allowed for expansion of
cobblestone-like bile duct colonies comprised of small cells
with large nuclear to cytoplasmic ratios (Fig. 5A). Expanded
fetal IHBD cells were EpCAM+, CD227+ and CK19+ and did
not express hepatocyte markers such as alpha-1 antitrypsin
(AAT) (Figs. 5B & C). CD227 (Mucin 1) is known to be
expressed on human fetal IHBD cells (Sasaki et al., 1995)
confirming that EpCAM+CD227+CK19+ cells are IHBD epithe-
lial cells and not hepatoblasts or hepatocytes. Therefore,
human fetal IHBD cells can be successfully expanded on LA7
feeder cells.
We screened expanded IHBD cells with the same panel of
cell surface markers used on gallbladder cells. Similar to the
gallbladder cells, we found that five independent IHBD cell
samples had a conserved phenotypic profile in vitro
(Supplementary table 5). Interestingly, we found that
expression of six cell surface markers CD13, CD227, CD66,
carcinoembryonic antigen-related cell adhesion molecule
(CEACAM), CD26, and CD49b (Integrin α2) was different
between expanded gallbladder and IHBD cells (Fig. 5D)
suggesting that these cells are distinct from each other. Wethen ran oligonucleotide microarrays on expanded EpCAM+
IHBD and gallbladder cells to evaluate differences in their
gene expression profiles.
EpCAM+ fetal IHBD and EpCAM+ fetal gallbladder cells
(n = 8 for each group) at early passage (bpassage 5) were
separated from rat feeder cells by Magnetic Activated Cell
Sorting (MACS) as previously described (Manohar et al.,
2011) (Supplementary Fig. 3). Principal component analysis
(PCA) revealed significant level of clustering between
IHBD (6 out of 8 samples) and gallbladder cells (6 out of 8
samples) (Fig. 5E). In addition, unpaired t-tests (BRB Analysis
Toolpack) revealed 715 transcripts that were significantly
different (p b 0.001, q b 0.05, fold change ≥ 2) between
the IHBD and gallbladder cells, of which 479 mapped to
known genes (Supplementary Table 6). We manually curated
this list and identified 193 genes that we considered
important for bile duct function (Fig. 5F). Interestingly, the
microarray analysis indicated that CD49b and CD66 were
upregulated in cultured gallbladder cells compared to IHBD
cells, confirming our phenotypic comparisons between the
two cell types (Fig. 5A) In addition, Mucin5 (MUC5) was
upregulated in gallbladder cells, an observation that has
266 R. Manohar et al.
267Identification of a candidate stem cell in human gallbladderbeen shown previously (Buisine et al., 2000). Aquaporin 5
(AQP5) was also found to be upregulated in gallbladder cells
adding to the current list of aquaporins (AQP8 and AQP4)
known to be differentially expressed between both cell
types (Portincasa et al., 2008). Other notable groups of
genes that were differentially expressed were the cyto-
chrome (CYP) P450 family, solute carrier (SLC) family as
well as other mucin family members (MUC13, 16 and 20)
and Indian hedgehog (Ihh). CYP and SLC family members
and Ihh are especially relevant as we have previously
identified that they are differentially expressed between
adult mouse IHBD and gallbladder stem cells (Manohar
et al., 2011). Pathway analysis suggested that lipid
metabolism (50 genes), vitamin and mineral metabolism
(20 genes), drug metabolism and carbohydrate metabolism
functions are different between gallbladder and IHBD cells
(Supplementary table 7). These data corroborate our
previous work that found that lipid metabolism and drug
metabolism are different between adult mouse IHBD and
gallbladder stem cells (Manohar et al., 2011). In all, the
phenotypic and transcriptional differences between human
expanded EpCAM+ gallbladder and IHBD cells confirm that
these cells are unique or distinct from each other and
suggest functional differences as well.Discussion
Here we reported a novel culture system that selects for
human gallbladder epithelial cells and supports single cell
self-renewal. In a previous study, Kobayashi et al. (1991) used
human gallbladder myofibroblasts as feeders to culture
gallbladder cells. However, their culture system does not
select for epithelial cells and clonal expansion was not
reported. Our use of the LA7 feeder cell culture system and
an epithelial cell marker (EpCAM) to definitively separate
epithelial from mesenchymal and hematopoietic cells, allows
for the identification of resident clonogenic cells from
gallbladder epithelium. This is especially important as we
identified EpCAM−CD13+ and EpCAM−CD44+ cells in primary
gallbladder (data not shown).Figure 5 Expanded gallbladder and IHBD cells have unique phenotyp
were plated on rat feeder cells. Usually following two passages, we ob
duct colonies were observed at the first expansion (p0). Representativ
cell expansion. (B) Immunofluorescence analysis of an IHBD culture sho
rat feeder cells. (C) Flow cytometric profile of IHBD6 (passage 1) showin
contours of live IHBD cells. Scale bars: 100 μm. (D) Expanded IHBD cells
screened on gallbladder cells (n = 5). We found expression of CD13, C
gallbladder and IHBD cells. All plots display 5% probability contours and
percentage of live gallbladder cells within that gate. (E) Oligonucleotid
gallbladder (GB) cells (n = 8) cells. PCAwas performed by Euclidean co
gallbladder cells (6 out of 8 samples) self-segregate into two indepe
(p b 0.001, q b 0.05, fold change≥2) between IHBD and gallbladder c
upregulated and 22 genes downregulated in gallbladder cells relative t
by using Euclidean distance measure and complete linkage. Black re
represents intensities that are greater than the mean; green represe
genes whose expression was adjusted to 0, when differentially regulate
bars: 100 μm.A key characteristic of stem cells is their ability to grow
from single cells and differentiate into lineage-committed
progeny. And for some stem cell populations clonogenicity in
vitro can be used as a surrogate assay for the identification of
their in vivo counterparts. Combined expression of EpCAM,
CD13 and CD44 highlighted specific heterogeneity on primary
gallbladder epithelial cells, allowing for their fractionation
into three distinct populations. We found that EpCAM+CD44+
CD13+ cells are the most enriched in colony forming ability,
exhibit single cell self-renewal and morphogenesis and give
rise to cultures in vitro that survived and engrafted in the
subcutaneous space of immunodeficient mice. These cells are
candidates to represent bona fide gall bladder stem cells
in vivo. As there are no specific markers of gallbladder
differentiation, we could only evaluate morphogenesis, but
not specific differentiation of gallbladder cells. Our in vitro
morphogenesis experiments were supported by in vivo
experiments, where we observed short-term (≤2 weeks)
engraftment of expanded gallbladder cells. Importantly, in
our previous work with adult mouse gallbladder cells, we also
only observed short-term engraftment of the cells (Manohar
et al., 2011). This could be for lack of growth stimulus from the
recipient animal. Moreover, the rate of self-renewal of
gallbladder cells in vivo is known to be low (Lamote and
Willems, 1997). We concluded that as the primary EpCAM+
CD44+CD13+ cells exhibited clonal self-renewal, expansion in
vitro and engraftment in vivo, they represent the most
clonogenic cell population from fetal gallbladder identified
to date.
It has recently been shown that murine IHBD and EHBD
systems develop from distinct stem cells (Spence et al., 2009).
In addition, we have found adult mouse gallbladder stem cells
to be unique or distinct compared to IHBD cells (Manohar et
al., 2011). We therefore chose to evaluate the differences
between fetal human IHBD cells and gallbladder cells. IHBD
epithelial cells expanded on LA7 feeder cells over several
passages while hepatoblasts and non-epithelial cells did not.
IHBD cells are thought to develop around seven or eight weeks
post gestation (Roskams and Desmet, 2008). Hepatoblasts that
are not involved in ductal plate formation, are CK19− by
around 14 weeks post gestation (Blankenberg et al., 1991). Byic and expression profiles. (A) Livers were digested and total cells
served a robust expansion of bile duct colonies. Occasionally bile
e pictures of 3 fetal liver samples at early passage indicating IHBD
wing that all cells were CK19+AAT− (arrowheads). Arrows indicate
g that all cells are EpCAM+CD227+. The plot display 5% probability
(n = 5) were screenedwith the same panel of cell surfacemarkers
D227, CD66, CD26, and CD49b were different between expanded
the number values assigned to the gates (red boxes) represent the
e microarrays were performed on expanded IHBD cells (n = 8) and
rrelation. The data indicate that IHBD cells (6 out of 8 samples) and
ndent groups. (F) Heatmap of 193 genes differentially regulated
ells defined in BRB Analysis Toolpack. This list comprises 171 genes
o IHBD cells. Heatmaps were generated in R (package-pheatmap)
presents genes whose expression was at the mean intensity; red
nts intensities that are less than the mean. White boxes indicate
d transcripts were initially defined in BRB Analysis Toolpack. Scale
268 R. Manohar et al.20 weeks of gestation, IHBD epithelial cells are CK19+ and
CD227+ (Blankenberg et al., 1991). All the fetal livers that we
processed were between 19 and 23 weeks of gestation.
Accordingly, we observed that expanded IHBD cells were
CK19+, CD227+, AAT− and EpCAM+, confirming expansion of
IHBD epithelial cells. It is possible that in vitro expansion may
select for a primitive population of IHBD cells, similar to what
we observe with gallbladder cells. However, the evaluation of
IHBD epithelial stem cells is beyond the scope of this study and
we accordingly referred to them simply as IHBD cells.
Phenotypic comparison of cultured IHBD and gallbladder
cells indicated differential expression of CD13, CD227, CD66,
CD26 and CD49b. These data are especially interesting, as
we have identified CD13 as enriching for clonogenic cells.
Foregoing phenotypic differences were corroborated by
transcriptional profiling of expanded gallbladder and IHBD
cells. PCA analysis showed that gallbladder and IHBD cells
clustered into two independent groups. In addition, assess-
ment of differentially regulated transcripts revealed a
substantial dataset (715 transcripts including 479 known
genes) replete with genes suggesting functional differences
in gallbladder and IHBD cells. We noted that CYP and SLC
families of genes, along with various mucins including MUC5,
were differentially expressed between gallbladder and IHBD
cells. Predictive functional analysis of the differentially
regulated genes indicated that lipid, vitamin and mineral,
carbohydrate, drug, and nucleic acid metabolisms could be
different between gallbladder and IHBD cells. In addition,
we found Interleukin 8, Interferon (IFN) receptor 1 and
Interleukin receptor 10 were upregulated in gallbladder
cells. The immunologic properties of bile duct cells have
been long considered and various inflammatory diseases
such as primary biliary cirrhosis (Hirschfield et al., 2010) and
biliary atresia (Bassett and Murray, 2008) directly affect bile
duct cells. They also play a causal role in liver allograft
rejection (Nakanuma et al., 2001). In addition, we have
previously identified differences in immunologic genes such
as IFN-inducible protein 27 between adult mouse IHBD cells
and gallbladder stem cells (Manohar et al., 2011), as well as
differences in drug and lipid metabolism and CYP and SLC
families of genes. This remarkable symmetry between our
human and mouse data indicate that differences between
gallbladder and IHBD cells persist from development through
to adulthood as well as across species. Although all of the
comparative studies were performed on cultured cells, we
believe that their in vivo counterparts are likely to show
similar differences.
In conclusion, the identification of fetal gallbladder stem
cells could have important ramifications for study of biliary
atresia and shed light on adult human gallbladder stem cells
and gallbladder cancer. These cells could also potentially be
reprogrammed into hepatocytes and endocrine cells as
demonstrated recently (Kuver et al., 2007; Lee et al.,
2009; Hickey et al., 2013). In addition, since laparoscopic
cholecystectomy became clinically available in 1989, the
removal of the gallbladder has become routine with
500,000–600,000 surgeries every year (MacFadyen et al.,
1998). This sheer volume of tissue along with candidate
plasticity of gallbladder stem cells makes them attractive
candidates for cell-based therapy.
Supplementary data to this article can be found online at
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